|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Kua-Wha Kuo | Kua-Wha Kuo | Sheng-Hui Chou | 06-3840890 | No.92,Keji 5th Rd., Annan Dist., Tainan CityAnnan Dist., Tainan 70955, Taiwan | 2011/03/21 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Business items are herbal medicine manufacture, western medicine manufacture, food product manufacture, cosmetic manufacture, and biotechnology service. The management system has been assessed and certified as meeting the requirements of ISO 9001:2000. The Research Center of Herbal Medicines of G&E has been certified by the Management Science Society of Taiwan (MSST), with the top quality and complete equipments. Dr. Kuo, Kou-Wha is the CEO of research center. He had worked as a professor in Kaohsiung Medical University for more than 23 years and had devoted most of the time in researching and developing the anti-cancer drugs. The herbal medicine SR-T100 which has been developed, has already obtained financial support from the Department of Economic of Taiwan to develop as a new botanic medicine for cancer in human clinical phase II trail. |
Market Information ( 2024/05/02 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
7.186 | 59.90 | 59.50 | 59.90 | 0.40 | 17 | .00 | N/A | N/A | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/05/02) |
TPEx measures adopted (2024/05/02) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |